Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients.
Zhong-Guo ZhouJin-Bin ChenRong-Xin ZhangLing YeJun-Cheng WangYang-Xun PanXiao-Hui WangWen-Xuan LiYao-Jun ZhangLi XuMin-Shan ChenPublished in: Cancer communications (London, England) (2020)
TESC was identified as an independent prognostic factor for short overall survival of HCC patients, and was critical for HCC cell proliferation and survival.